2 incredible ASX shares I'd buy with $2,000 right now

These investments have global growth potential…

Key points
  • Breville Group Ltd (ASX: BRG) is an attractive buy due to its global expansion and recent price decline, with plans to mitigate tariff impacts by relocating manufacturing outside China, enhancing its growth prospects.
  • Betashares Global Quality Leaders ETF (ASX: QLTY) offers exposure to high-quality global stocks, focusing on companies with strong ROE, cash flow, stable earnings, and low debt, with a proven track record of delivering solid returns since inception.
  • Both investments provide opportunities for exposure to international markets and potential long-term growth, with Breville capitalising on new geographic markets and QLTY focusing on quality global leaders.

There are some impressive businesses on the ASX that are growing rapidly in Australia, but they're currently limited to the local market. I think the big opportunities are with ASX shares that have their sights on the global economy, where there's a lot more growth potential.

Some of the ASX's best long-term performers such as Pro Medicus Ltd (ASX: PME) and Aristocrat Leisure Ltd (ASX: ALL) have become as large as they are by successfully expanding overseas.  

The two ASX share investments below are ones to watch (and buy) in my book with $2,000.

a hand reaches out with australian banknotes of various denominations fanned out.

Image source: Getty Images

Breville Group Ltd (ASX: BRG)

Breville is one of the world's largest coffee machine businesses, owning a number of brands, including Breville, Safe, Lelit, Baratza, and its coffee bean business, Beanz.

I think the FY25 result demonstrated the company's ability to deliver solid compounding growth. Revenue, net profit and the dividend all increased by more than 10%, which was solid in my view.

The 25% decline of the Breville share price since January makes it look like a much cheaper buy. There are tariff headwinds for the business in FY26, but it's rapidly working to shift manufacturing for the American market to Mexico, which should lessen the headwind.

I don't believe the tariffs will be a long-term headwind for the business, making it an appealing buy at this cheaper valuation, in my opinion. Management expects that US products (representing 80% of gross profits dollars) will be manufactured outside of China by the end of the FY26 first half.

On the purely positive side, Breville's expansion into new geographic markets, such as the recent additions of China and the Middle East, gives the company more avenues for growth.

According to the forecast on CMC Markets, the ASX share is trading at less than 27x FY27's estimated earnings, which I'm calling good value given its long-term growth potential.

Betashares Global Quality Leaders ETF (ASX: QLTY)

There are plenty of great businesses listed outside of the ASX share market. The ASX only accounts for around 2% of the global stock market, so I strongly believe it's a good idea to get exposure to those companies too.

While there are many thousands of businesses we could invest in overseas, I'd only advocate for investing in the best or most exciting names.

The QLTY ETF looks to invest in the 150 highest-quality global stocks. Those names are chosen for the portfolio based on four factors: a high return on equity (ROE), good cash flow generation, stable earnings and low debt levels.

When you put those elements together, only the very best names will make it into the portfolio, in my view.

The investment process is clearly working well so far because the QLTY ETF has returned an average of 14.6% per year since it was started in November 2018. Past performance is not necessarily a reliable indicator of future performance, but I think this fund is capable of delivering average annual returns in excess of 10% per year over the long term because of its pure focus on quality holdings.

Motley Fool contributor Tristan Harrison has positions in Breville Group and Pro Medicus. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has recommended Pro Medicus. The Motley Fool Australia has recommended Pro Medicus. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Opinions

Piles of increasing coins alongside an hourglass.
Opinions

Why I'm planning to buy more Soul Patts shares in 2027

I think Soul Patts is a great long-term buy.

Read more »

a close up of a woman's face looks skywards as she is showered in a sea of graphic symbols of gold and silver coins bearing the bitcoin logo.
Cryptocurrencies

Are you a 'greater fool' for owning Bitcoin?

Is Bitcoin truly an investment?

Read more »

A little girl is surprised at a science experiment.
Opinions

2 ASX shares with the potential to double in a year, and the risk that keeps me cautious

One of these ASX shares could climb up to 123% higher.

Read more »

A man in business attire plunges into water.
Opinions

My 2027 ASX shortlist started with 50 shares. It ended with these 3

There's no such thing as a perfect ASX share, but these three tick my boxes.

Read more »

A man in a business suit uses a rope to climb up the side of a huge pile of papers fashioned like a tall building against a blue sky backdrop with clouds representing an assessment of whether CBA shares stacked up well in March
Opinions

CBA shares: I investigated the bull and bear case. Here's my verdict

The market is split, so I did my own research.

Read more »

A couple hang off their car looking at the sun rising over the horizon.
Opinions

There's one ASX share I'd happily hold for 10 years. This is it

I think this ASX share can stand the test of time.

Read more »

A male investor sits at his desk looking at his laptop screen holding his hand to his chin pondering whether to buy Macquarie shares
Opinions

Down doesn't mean cheap. 3 ASX shares off their highs, and the one I'd actually consider

Here's my view on these three ASX shares.

Read more »

A woman sits on sofa pondering a question.
Opinions

WiseTech shares: I've looked into the bull and the bear case, and come to my own conclusion

Is the beaten-down ASX tech stock on a path to recovery, or does the latest increase create a false sense…

Read more »